Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_630f924c1eea9d4921e893ad6c349c9b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-79 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6842 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
filingDate |
2003-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fbb66af515a95906a8a5e96a1c70270 |
publicationDate |
2004-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1378521-A1 |
titleOfInvention |
Anti-Carbohydrate Deficient Transferrin (CDT) spezific antibody, its production and use |
abstract |
The present invention relates to antibodies that are selective in aqueous solutionnbind a transferrin homolog "carbohydrate deficient transferrin" (CDT),nwithout being bound to a solid phase. CDT is through itncharacterized in that at least one of the two oligosaccharide chains, thenare normally bound to Asn 413 and / or Asn 611 of the transferrin,nmissing entirely or essentially. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014144060-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015135900-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116041506-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013071127-A1 |
priorityDate |
2002-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |